Skin specialists Dr. Anand K. Ganesan and Dr. Jessica Shiu

Jun 22, 2023

Breakthroughs offer hope for vitiligo patients

In 2018, Dr. Anand K. Ganesan (above left) opened a vitiligo specialty practice lab at the UCI Health Beckman Laser Institute & Medical Clinic, hoping to find new therapies to reverse the disfiguring skin disorder. Now, the lab has produced a topical cream called ruxolitinib, the first therapy approved by the U.S. Federal Drug Administration that restores pigment in vitiligo patients. The FDA also recently gave breakthrough device approval for RECELL®, a one-time therapy using the patient’s healthy cells to stimulate lasting repigmentation in stable vitiligo.

Headshot of Min Zhang

Jun 21, 2023

Cancer researchers learn about big data analysis using Anvil

The BigCare workshop, otherwise known as the “Big Data Training for Cancer Research,” is a program funded by the National Cancer Institute (NCI). The purpose of the workshop is to help cancer researchers develop the requisite skills for managing, visualizing, analyzing, and integrating various types of “omics” data in cancer studies. BigCare was founded in 2020 by Min Zhang, PhD, a professor of epidemiology and biostatistics at the University of California, Irvine’s Program in Public Health, as well as the biostatistics shared resources director for the UCI Chao Family Comprehensive Cancer Center.

Headshot of Alexandre Chan

Jun 20, 2023

FDA Approves New Drug Combo For Prostate Cancer

Alexandre Chan, PharmD, MPH, professor of clinical pharmacy at the School of Pharmacy & Pharmaceutical Sciences at University of California, Irvine is similarly excited about the prospect of this combination of medications being better understood and implemented. “I think that’s good news for patients, in the sense that there are additional therapies that we can use at first line and [they] have demonstrated that if you have the proper mutations, you get much better progression free and also overall survival.”
Headshot of Selma Masri

Jun 14, 2023

Adjusting Your Body Clock May Stave Off Cancer

For some time now epidemiological studies of night-shift workers have linked disruptions in circadian rhythms to cancer and other diseases. … “We're starting to understand the reasons these things happen,” says Selma Masri, a circadian biologist and assistant professor at the University of California, Irvine, who has shown how circadian disruption pushes colon cancer progression by interfering with the way certain genes are expressed.
Person running towards finish line at Anti-Cancer Challenge

Jun 13, 2023

UCI Anti-Cancer Challenge hits milestone in search for next breakthrough cancer treatments

The UCI Anti-Cancer Challenge has raised over $1 million in 2022, funding 28 new projects and reaching 100 total, all focused on advancing cancer treatment and cures.
Headshot of Jason Zell

Jun 09, 2023

Rise in colorectal cancer among young adults an alarming trend

The rise in colon cancer rates among millennials has been alarming. "Physicians are aware, primary care doctors are aware, oncologists are aware, and I am not sure the public is aware that it is a real issue," said Dr. Jason Zell, at UCI Health Chao Family Comprehensive Cancer Center and UCI associate professor.
Headshot of Michael Hoyt

Jun 08, 2023

UC Irvine study finds that lesbian, gay and bisexual cancer survivors experience more health-related challenges compared to heterosexual counterparts

Public health researchers from the University of California, Irvine have determined that lesbian, gay and bisexual cancer survivors experience a lower quality of life compared to their heterosexual counterparts, specifically in the mental and social aspects of their overall health. Corresponding author Michael Hoyt, PhD, associate professor of population health and disease prevention from UCI’s Program in Public Health, and his collaborators published their findings in the Journal of Psychosocial Oncology.

Daniela Bota in Lab

Jun 07, 2023

The Audley Fund of the Philadelphia Foundation backs Dr. Daniela Bota's search for a glioblastoma cure

UCI Health and neuro-oncologist Dr. Daniela A. Bota, MD are pleased to receive a third consecutive grant from The Audley Fund of the Philadelphia Foundation to support research to find a cure for brain cancer, especially glioblastoma.
Headshot of Jung In Park

Jun 06, 2023

Jung In Park, University of California, Irvine – Survival Machine Learning for Breast Cancer Patients

Racial disparities can exist even in machine learning. Jung In Park, assistant professor in the Sue & Bill Gross School of Nursing at the University of California, Irvine, finds a way to tackle biases and make a difference for vulnerable populations